Biggest Industry Players Face Pressure from Public and the DEA on Suspicious Order Monitoring
Spread the love

Biggest Industry Players Face Pressure from Public and the DEA on Suspicious Order Monitoring

The Opioid Epidemic has been a devastating trend in America, starting in the late 1990s and continuing over twenty years through today. Experts believe that the glut of prescription narcotics (OxyCodone, Percocet) has caused an increase in illegal opiates (heroin) use; and with it, preventable addictions and deaths. Only over the last year, however, has it become mainstream news – and with it has come mainstream responsibility. A few events in the last 6 months including the POTUS declaring War on Opioids; 60 Minutes releasing a scathing report on McKesson; a report that opioids cause more deaths than motor vehicle crashes; and, DEA whistleblowers claiming Congress is complicit in the Diversion.

Opioid Epidemic

The Opioid Epidemic is, concisely, the trend of increasing drug overdose and opioid-involved deaths in America. Over the last 20 years, the number of opioid-related overdose deaths has quadrupled – a total of 500,000 deaths between 2000 and 2015 or 91 Americans per day.

Feeling the Pressure – Amerisource Bergen

In December 2017, the AmerisourceBergen Foundation announced a support program to help combat opioid abuse, specifically providing municipalities drug deactivation resources to help ensure unused narcotics do not end up in the wrong hands.

Feeling the Pressure McKesson

60 Minutes and the Washington Post worked together to investigate how McKesson allegedly worked with Congress to make billions of dollars through the illegal diversion of narcotics. In a response, McKesson highlighted a comprehensive program that they utilize to limit drug diversion. One of the key parts of their fighting opioid abuse is a multi-million dollar investment into Suspicious Order Monitoring.

NavigateSOM, a Pharma Solutions Solution

Starting in 2017, the DEA has made it clear that both distributors and manufacturers are responsible for implementing adequate controlled substance Suspicious Order Monitoring software.

About Us

Based just outside of Philadelphia, Pharma Solutions provides actionable guidance and excellent administrative services with a focus on client care across Compliance, Commercial, and Quality solutions. Our mission is to improve the health and welfare of the American public by providing solutions and implementing best practices for companies in the pharmaceutical supply chain.


Submit a Comment

Your email address will not be published. Required fields are marked *